Literature DB >> 31659284

Anti-VEGF therapy is not a magic bullet for diabetic retinopathy.

Mingwei Zhao1,2,3, Yaoyao Sun4,5,6, Yuzhen Jiang7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31659284      PMCID： PMC7265293          DOI： 10.1038/s41433-019-0652-3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  2 in total

1.  Retinal Inflammation, Oxidative Stress, and Vascular Impairment Is Ablated in Diabetic Mice Receiving XMD8-92 Treatment.

Authors:  Scott J Howell; Chieh A Lee; Julia C Batoki; Thomas E Zapadka; Sarah I Lindstrom; Brooklyn E Taylor; Patricia R Taylor
Journal:  Front Pharmacol       Date:  2021-08-11       Impact factor: 5.810

2.  Proliferative retinopathy as a feature of Vogt Koyanagi Harada Disease: a report of two cases.

Authors:  Moustafa S Magliyah; Abdulmajeed S Al-Fakhri; Hassan A Al-Dhibi
Journal:  BMC Ophthalmol       Date:  2020-12-01       Impact factor: 2.209
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.